Y. Yamazaki

发表

Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter

S. Tokuyama, S. Harada, Y. Yamazaki, 2012, Brain Research.

Effects of scavenger receptors-1 class A stimulation on macrophage morphology and highly modified advanced glycation end product-protein phagocytosis

M. Nishibori, Hideo Takahashi, S. Mori, 2018, Scientific Reports.

Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage

S. Tokuyama, S. Harada, Y. Yamazaki, 2014, Neuroscience.

Activation of c-Jun N-terminal kinase and p38 after cerebral ischemia upregulates cerebral sodium-glucose transporter type 1.

S. Tokuyama, S. Harada, Y. Yamazaki, 2018, Journal of pharmacological sciences.

Involvement of multiple scavenger receptors in advanced glycation end product-induced vessel tube formation in endothelial cells.

T. Yoshino, M. Nishibori, Hideo Takahashi, 2021, Experimental cell research.

Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis

T. Yoshino, M. Nishibori, Hideo Takahashi, 2018, Front. Immunol..

A comparative study of sulphated polysaccharide effects on advanced glycation end-product uptake and scavenger receptor class A level in macrophages

T. Yoshino, M. Nishibori, Hideo Takahashi, 2020, Diabetes & vascular disease research.

Relationship between cerebral sodium–glucose transporter and hyperglycemia in cerebral ischemia

S. Tokuyama, S. Harada, Y. Yamazaki, 2015, Neuroscience Letters.

Alterations of lymphocyte count and platelet volume precede cerebrovascular lesions in stroke-prone spontaneously hypertensive rats

T. Yoshino, M. Nishibori, Hideo Takahashi, 2020, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Neuroprotective effect through the cerebral sodium–glucose transporter on the development of ischemic damage in global ischemia

S. Tokuyama, S. Harada, Y. Yamazaki, 2013, Brain Research.

Sodium–glucose transporter as a novel therapeutic target in disease

S. Tokuyama, S. Harada, Y. Yamazaki, 2018, European journal of pharmacology.

RETRACTED: Cerebral ischemia-induced elevation of hepatic inflammatory factors accompanied by glucose intolerance suppresses hypothalamic orexin-A-mediated vagus nerve activation

S. Tokuyama, S. Harada, Y. Yamazaki, 2017, Brain Research.

Sodium transport through the cerebral sodium–glucose transporter exacerbates neuron damage during cerebral ischaemia

T. Wada, S. Yoshida, S. Tokuyama, 2016, The Journal of pharmacy and pharmacology.

Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor

S. Tokuyama, S. Harada, Y. Yamazaki, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia

S. Tokuyama, S. Harada, S. Ogihara, 2015, Neuroscience.

Hepatic Branch Vagus Nerve Plays a Critical Role in the Recovery of Post-Ischemic Glucose Intolerance and Mediates a Neuroprotective Effect by Hypothalamic Orexin-A

S. Koda, S. Tokuyama, S. Harada, 2014, PloS one.

Sodium influx through cerebral sodium‐glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage

T. Wada, S. Yoshida, S. Tokuyama, 2017, European journal of pharmacology.